Ocumension Therapeutics Announces Inclusion of Its Shares in the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs Mar 13, 2023 18:30 HKT/SGT Read More
Eisai Receives the "Basic Achievement Grand Prize" at the 2023 J-Win Diversity Award Mar 10, 2023 14:04 HKT/SGT Read More
Eisai Certified as a 2023 Health and Productivity Management Outstanding Mar 09, 2023 08:07 HKT/SGT Read More
OrbusNeich Announces First Annual Results After Listing, Record Revenue of US$136.8 Million, Adjusted Net Profit Up 25% to US$26.7 Million Mar 08, 2023 18:00 HKT/SGT Read More
With U.S. Health Systems Under Growing Pressure to Fill Staff Vacancies, CGFNS Alliance Releases Updated Standards for Ethical Recruitment of Foreign Health Workers Mar 07, 2023 13:30 HKT/SGT Read More
EC Healthcare Opened the First Organic Flagship Veterinary Hospital in Hong Kong Mar 06, 2023 15:50 HKT/SGT Read More
エーザイ、「LEQEMBI」についてアルツハイマー病治療薬としてフル承認に向けた生物製剤承認一部変更申請(sBLA)が米国FDAに受理され、優先審査に指定 Mar 06, 2023 10:00 JST Read More
FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBITM (lecanemab-irmb) for the Treatment of Alzheimer's Disease Mar 06, 2023 09:58 HKT/SGT Read More